İsmail Baydili, Burak Tasci, Gülay Tasci, Sengul Dogan, Turker Tuncer
{"title":"Artificial Intelligence in Healthcare: From Predictive Models to Generative, Multimodal, and Agentic AI.","authors":"İsmail Baydili, Burak Tasci, Gülay Tasci, Sengul Dogan, Turker Tuncer","doi":"10.3390/bioengineering13101175","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) is increasingly used across the diagnostic pathway, from screening and disease detection to differential diagnosis, prognostic stratification, and treatment-response assessment. This narrative review examines predictive, generative, multi-modal, and agentic AI through a diagnostic-science lens and evaluates the evidence required for translation into clinical practice. Predictive models can identify complex patterns in images, physiological signals, laboratory data, and electronic health records, but high retrospective accuracy does not establish diagnostic utility. Clinical validity and utility depend on the intended use, target population, disease spectrum and prevalence, reference standard, operating threshold, calibration, and the consequences of false-positive and false-negative results. Generative AI may support problem representation, differential diagnosis, information synthesis, and documentation, yet fluent outputs can omit critical alternatives, amplify false premises, or convey unjustified certainty. Multimodal systems may better reflect clinical reasoning by integrating imaging, text, signals, pathology, and molecular data, but they must demonstrate incremental value over the best single-modality test and remain robust to missing data. Agentic systems can coordinate evidence retrieval, test selection, and sequential workflows, thereby increasing the need for bounded permissions, auditability, error recovery, and human escalation. Across all paradigms, a credible pathway to diagnostic implementation requires independent external and prospective validation, representative consecutive patients, subgroup analysis, workflow and human-AI evaluation, clinical impact studies, and post-deployment surveillance. The field should therefore be judged not by model capability alone, but by whether AI measurably improves diagnostic yield, timeliness, safety, equity, and patient-relevant outcomes in real care settings.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"13 10","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13701811/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering13101175","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Artificial intelligence (AI) is increasingly used across the diagnostic pathway, from screening and disease detection to differential diagnosis, prognostic stratification, and treatment-response assessment. This narrative review examines predictive, generative, multi-modal, and agentic AI through a diagnostic-science lens and evaluates the evidence required for translation into clinical practice. Predictive models can identify complex patterns in images, physiological signals, laboratory data, and electronic health records, but high retrospective accuracy does not establish diagnostic utility. Clinical validity and utility depend on the intended use, target population, disease spectrum and prevalence, reference standard, operating threshold, calibration, and the consequences of false-positive and false-negative results. Generative AI may support problem representation, differential diagnosis, information synthesis, and documentation, yet fluent outputs can omit critical alternatives, amplify false premises, or convey unjustified certainty. Multimodal systems may better reflect clinical reasoning by integrating imaging, text, signals, pathology, and molecular data, but they must demonstrate incremental value over the best single-modality test and remain robust to missing data. Agentic systems can coordinate evidence retrieval, test selection, and sequential workflows, thereby increasing the need for bounded permissions, auditability, error recovery, and human escalation. Across all paradigms, a credible pathway to diagnostic implementation requires independent external and prospective validation, representative consecutive patients, subgroup analysis, workflow and human-AI evaluation, clinical impact studies, and post-deployment surveillance. The field should therefore be judged not by model capability alone, but by whether AI measurably improves diagnostic yield, timeliness, safety, equity, and patient-relevant outcomes in real care settings.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering